TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).

Hope S Rugo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.